Transcatheter therapy of structural heart disease is advancing rapidly. Due to the less invasive approach, transcatheter techniques have replaced surgery as the standard procedure for atrial septal defect and patent foramen ovale closure.

Evolving interventional techniques allow treatment of paravalvular leaks, ventricular septal defects and valve replacement, especially the rapid evolution and newer indications for transcatheter aortic valve replacement (TAVR).

Related Articles


Pre-excitation Associated with Rheumatic Mitral Stenosis

Jogendra Singh, Dibyasundar Mahanta, Rudra Pratap Mahapatra,


Citation: Journal of Asian Pacific Society of Cardiology 2022;1:e03.

APSC Consensus Recommendations for MitraClip in MR

Khung Keong Yeo, MBBS, Jack Wei Chieh Tan, David WM Muller,


Citation: European Cardiology Review 2021;16:e25.

Pathology of First-generation Drug-eluting Stents in Humans

Fumiyuki Otsuka, Masataka Nakano, Saami K Yazdani,

Citation: Asia-Pacific Cardiology 2011;3(1):52-9

Non-cardiac Surgery Following Drug-eluting Stents

Dev Pahlajani,

Citation: Asia-Pacific Cardiology 2007;1(1):40-1